Table 1.
Patient characteristics.
| Characteristics | n (%) |
|---|---|
| Age, y | |
| ≥50 | 48 (68.6) |
| <50 | 22 (31.4) |
| Gender | |
| Male | 59 (84.3) |
| Female | 11 (15.7) |
| Stage T | |
| T3 | 65(92.9) |
| T4 | 5(7.1) |
| Stage N | |
| N0 | 48(68.6) |
| N1 | 22(31.4) |
| Stage M | |
| M0 | 57(81.4) |
| M1 | 13(18.6) |
| Types of PVTT | |
| II | 42 (60.0) |
| III | 27 (38.6) |
| IV | 1 (1.4) |
| HBsAg | |
| Negative | 12 (17.1) |
| Positive | 58 (82.9) |
| Child-Pugh classification | |
| A | 45 (64.3) |
| B | 24 (34.3) |
| C | 1 (1.4) |
| ECOG | |
| 0 | 56 (80.0) |
| 1 | 14 (20.0) |
| AFP, ng/L | |
| ≤20 | 13 (18.6) |
| 21~399 | 17 (24.3) |
| ≥400 | 40 (57.1) |
| PLT, 109/L | |
| ≥100 | 39 (55.7) |
| <100 | 31 (44.3) |
| HGB, g/L | |
| ≥120 | 42 (60.0) |
| <120 | 28 (40.0) |
| TBIL, μmol/L | |
| ≥20 | 34 (48.6) |
| <20 | 36 (51.4) |
| ALB, g/L | |
| ≥35 | 41 (58.6) |
| <35 | 29 (41.4) |
| ALT, U/L | |
| ≥50 | 25 (35.7) |
| <50 | 45 (64.3) |
| AST, U/L | |
| ≥50 | 48 (68.6) |
| <50 | 22 (31.4) |
PVTT, Portal vein tumor thrombus; HBsAg, Hepatitis B surface antigen; PS, Performance status; ECOG, Eastern Cooperative Oncology Group; AFP, Alpha–fetoprotein; PLT, Platelet; HGB, Hemoglobin; TBIL, Total bilirubin; ALB, Albumin; ALT, Alanine aminotransferase; AST, Aspartate aminotransferase.